Last reviewed · How we verify
NCT04284046
CT Scores Predict Mortality in 2019-nCoV Pneumonia
trial testing CT score in CT Scores Predict Mortality in 2019-nCoV Pneumonia in 39 participants. Completed in 18 February 2020.
18 February 2020
Quick facts
| Lead sponsor | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 39 |
| Start date | 31 January 2020 |
| Primary completion | 18 February 2020 |
| Estimated completion | 18 February 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- CT score
Conditions studied
- CT Scores Predict Mortality in 2019-nCoV Pneumonia — all drugs for CT Scores Predict Mortality in 2019-nCoV Pneumonia →
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Who can join
Eligibility, any sex, with CT Scores Predict Mortality in 2019-nCoV Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
While 2019-nCoV nucleic acid swab tests has high false positives rate, How to diagnose 2019-nCoV pneumonia and predict prognosis by CT is very important.In this retrospective single-center study, we consecutively included suspected 2019-nCoV pneumonia critical cases in the intensive care unit of Wuhan third hospital from January 31, 2020 to February 16, 2020. The cases were confirmed by real-time RT-PCR, and all patients were evaluated with CT, cutoff values were obtained according to the Yoden index, and were divided into high CT score group and low CT score group. Epidemiological, demographic, clinical, and laboratory data were collected.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Outbreak of COVID-19: An emerging global pandemic threat.
Peng M. · · 2020 · cited 42× · PMID 32768974 · DOI 10.1016/j.biopha.2020.110499 -
The outlook for diagnostic purposes of the 2019-novel coronavirus disease.
Tahmasebi S, Khosh E, Esmaeilzadeh A. · · 2020 · cited 29× · PMID 32452050 · DOI 10.1002/jcp.29804 -
CT scores predict mortality in 2019-nCoV pneumonia
Xie Y, Yang L, Dong H, Peng H, et al · · 2020 · DOI 10.21203/rs.3.rs-16201/v1
Verify or expand the search:
- PubMed search for NCT04284046
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine trials
Trials by the same sponsor.
- NCT06667466 — New Laser and Suction Sheath for Kidney Stone Treatment · not yet recruiting
- NCT07043374 — Impact of Humid-Heat on Gut-Tryptophan-Stone Pathway · not yet recruiting
- NCT07415226 — Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes · not yet recruiting
- NCT07469046 — VAH vs VA in Newly Diagnosed Elderly AML · Phase 3 · not yet recruiting
- NCT07439120 — Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04284046 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Last refreshed: 25 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04284046.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing